dr. ledermann on parp inhibitors in maintenance therapy for ovarian cancer
Published 5 years ago • 424 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
1:20
dr. ledermann on rationale for ariel3 trial in ovarian cancer
-
7:10
jonathan a ledermann – maintenance treatment for recurrent ovarian carcinoma
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
0:58
dr. ledermann on systemic treatment for rare gynecologic tumors
-
4:17
maintenance therapy in ovarian cancer: parp inhibitors
-
1:26
parp inhibitors for maintenance therapy in ovarian cancer
-
7:56
maintenance therapy in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
1:14
dr. ledermann on the treatment landscape for rare gynecologic cancers
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
3:07
rucaparib maintenance and monotherapy for ovarian cancer: trial updates
-
7:38
parp maintenance therapy in recurrent ovarian cancer
-
6:25
niraparib maintenance therapy for ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
29:51
evaluating clinical pathways for ovarian cancer treatment and maintenance therapy
-
59:02
parp inhibitors as first-line maintenance therapy in ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer